North America Colorectal Cancer Screening Market Size (2024 - 2029)

North America Colorectal Cancer Screening Market Analysis

The North America Colorectal Cancer Screening Market size is estimated at USD 7.15 billion in 2024, and is expected to reach USD 9.89 billion by 2029, growing at a CAGR of 6.70% during the forecast period (2024-2029).

• The North American colorectal cancer screening market is experiencing growth due to several factors, such as the increasing prevalence of colorectal cancer, technological advancements, and cancer prevention initiatives. The high prevalence of colorectal cancers in the region is one of the major factors driving the market growth, as it is expected to increase the usage of colorectal cancer screening tests.
• For instance, according to data published by the Canadian Cancer Society in May 2024, colorectal cancer is expected to be the fourth most commonly diagnosed cancer in Canada in 2024. In addition, according to the same source, 25,200 new colorectal cancer cases are estimated to be diagnosed in Canada in 2024. Similarly, according to the data published by the International Agency for Research on Cancer in February 2024, the number of new colorectum cancer cases was reported to be 16.1 thousand cases in 2022 and is estimated to reach 17.5 thousand cases in Mexico by 2025. Thus, the increasing prevalence of colorectal cancer is driving the need for screening, which is expected to contribute to market growth during the forecast period significantly. Moreover, colorectal cancer prevention initiatives are expected to boost the market growth. For instance, according to the data updated by Ohio State University in 2023, the Ohio Colorectal Cancer Prevention Initiative (OCCPI) is a statewide initiative in Ohio, United States, to screen newly diagnosed colorectal cancer (CRC) patients and their biological relatives for Lynch syndrome. This cancer-causing condition occurs when a person inherits a mutation in one of four genes. These initiatives increase the awareness of colorectal cancer screening, thereby boosting the demand, and are expected to drive market growth during the forecast period.
• Thus, the above factors, such as the rising prevalence of colorectal cancer and cancer prevention initiatives, are expected to boost the market growth. However, high screening test costs are expected to impede market growth during the forecast period.

North America Colorectal Cancer Screening Industry Segmentation

As per the report's scope, colorectal cancer (CRC) is also known as bowel cancer and colon cancer. It is a cancer of the colon or rectum, usually located at the digestive tract's lower end. Colorectal cancer screening tests use kits and various medical devices to diagnose cancer. The North American colorectal cancer screening market is segmented by screening tests, end users, and geography. The market is segmented by screening tests into stool-based tests, colonoscopy, CT colonography, flexible sigmoidoscopy, and other screening tests. The other screening tests include liquid biopsy, double-contrast barium enema (DCBE), and other tests. By end users, the market is segmented into hospitals, diagnostic centers/laboratories, and other end users. The other end users include gastrointestinal clinics and specialty care centers. The market is segmented by geography into the United States, Canada, and Mexico. The report offers the value (in USD) for the above segments.